Stockholder's Equity (Deficit) | Note 9 – Stockholders’ Equity (Deficit) Series C Preferred Stock On February 24, 2021, the Company sold 179,850 of its Series C Convertible Preferred Shares, with an annual accruing dividend of 10%, to Geneva Roth Remark Holdings, Inc. (“Geneva”), for $163,500 pursuant to a Series C Preferred Purchase Agreement with Geneva. The Company may redeem the Series C Shares at various increased prices at time intervals up to the 6-month anniversary of the closing and must redeem any outstanding shares on the 24-month anniversary. Geneva may convert the Series C Shares into our common shares, commencing on the 6-month anniversary of the closing at a 30% discount to the public market price. The Company recorded a derivative liability associated with Series C Preferred Shares of $1,082,441, valued using a Binomial Option Pricing Model. On March 16, 2021, the Company sold an additional 113,850 shares for $103,500 and recorded a derivative of $177,231. The Series C Preferred Stock is classified as temporary equity due to the fact that the shares are redeemable at the option of the holder. There were 293,700 shares outstanding at March 31, 2021, with an associated derivative liability of $386.845. The tables below provide the preferred stock activity for the three months ended March 31, 2021 and 2020, and also a reconciliation of the beginning and ending balances for the derivative liabilities measured using Level 3 fair value inputs for the three months ended March 31, 2021 and 2020: Preferred Discount Preferred Derivative Balance , December 31, 2020 $ — — — — Issuance of Series C Preferred shares 293,700 293,700 — 1,259,672 Accretion of discount — (10,963 ) 10,963 — Accretion of dividend on Series C preferred stock 2,192 — 2,192 2,866 Change in fair value of derivatives — — — (875,693 ) Balance March 31, 2021 $ 295,892 $ 282,737 $ 13,155 $ 386,845 Preferred Discount Preferred Derivative Balance , December 31, 2019 $ 140,000 $ 131,250 $ 8,750 $ 190,131 Issuance of Series C Preferred shares 55,800 55,800 — 88,868 Accretion of discount — (14,809 ) 14,809 — Accretion of dividend on Series C preferred stock 4,779 — 4,779 — Change in fair value of derivatives — — — 13,688 Balance March 31, 2020 $ 200,579 $ 172,241 $ 28,338 $ 292,687 The following assumptions were used in the Binomial Option Pricing Model in calculating the embedded conversion features and current liabilities for the three months ended March 31, 2021 and 2020: 2021 2020 Risk-free interest rates 0.12 – 0.16 % 0.23 – 0.71 % Expected life (years) 1.9 – 2.0 1.7 – 2.0 Expected dividends 0 % 0 % Expected volatility 188 – 196 % 246 – 251 % Common Stock 2021 Transactions During the three months ended March 31, 2021, $100,000 of notes and $6,256 of accrued interest and fees were converted into 5,026,413 shares of common stock with a value of $705,635. During the three months ended March 31, 2021, 606,769 shares of common stock, valued at $24,843, were accrued for related party services. At March 31, 2021 and December 31, 2020, shares to be issued for related party services were 2,338,456 and 1,731,687, respectively, and the value of shares to be issued at March 31, 2021 and December 31, 2020 was $38,207 and $13,364, respectively. During the three months ended March 31, 2021, 31,696 shares of common stock, valued at $2,000, were accrued for services. At March 31, 2021 and December 31, 2020, shares to be issued for services were 1,137,553 and 1,105,857, respectively, and the value of shares to be issued at March 31, 2021 and December 31, 2020 was $16,000 and $14,000, respectively. At March 31, 2021 and December 31, 2020, shares to be issued for debt conversions were 31,960, and the value of shares to be issued was $21,861. During the three months ended March 31, 2021, we issued 30,000 shares of common stock, valued at $1,915, for consulting services. 2020 Transactions During the three months ended March 31, 2020, $89,000 of notes, $6,282 of accrued interest and $210 additional fee was converted into 13,767,631 shares of common stock. As of March 31, 2020, 35,844 shares, valued at $35,844 for debt conversion were authorized, but not issued as of March 31, 2020. As March 31, 2020, 406,160 shares, valued at $13,601 for services were authorized, but not issued as of March 31, 2020. These were classified as shares to be issued at March 31, 2020. As March 31, 2020, 4,951,781 shares, valued at $106,842 for related party services were authorized, but not issued as of March 31, 2020. These were classified as shares to be issued at March 31, 2020. Common stock warrant activity: The Company has determined that certain of its warrants are subject to derivative accounting. The table below provides a reconciliation of the beginning and ending balances for the warrant liabilities measured using fair significant unobservable inputs (Level 3) for the three months ended March 31, 2021 and 2020: Three Months ended March 31, 2021 2020 Balance at beginning of year $ 476 $ 967 Additions to derivative instruments — — Loss (gain) on change in fair value of derivative liability 4,442 (97 ) Balance at end of year $ 4,918 $ 870 11 The following assumptions were used in the Binomial Option Pricing Model in calculating the embedded conversion features and current liabilities for the three months ended March 31, 2021 and 2020: March 31, 2021 March 31, 2020 Annual dividend yield 0 % 0 % Expected life (years) 1.75 – 6.13 0.42 – 8.13 Risk-free interest rate 0.16 – 1.16 % 1.56 – 2.40 % Expected volatility 198 – 243 % 165 – 318 % |